EVOQ Remedies Ltd.

BSE: 543500

₹1.62

up-down-arrow0.02 (1.25%)

As on 02-Sep-2026IST

Market cap

info icon

₹4 Cr

Revenue (TTM)

info icon

₹12 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.1

Div. Yield

info icon

0 %

EVOQ Remedies Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 1.53 High: 1.62

52 Week Range

Low: 1.53 High: 6.11

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹0 Cr

  • ROEROE information

    0.3 %

  • ROCEROCE information

    0.3 %

  • Industry P/EIndustry P/E information

    26.81

  • EV/EBITDAEV/EBITDA information

    -19.1

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹17.9

  • EPSEPS information

    ₹0

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    24,900,000

7 Years Aggregate

CFO

₹-40.06 Cr

EBITDA

₹-5.17 Cr

Net Profit

₹3.98 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
EVOQ Remedies
-49.2 -4.7 -49.7 -52.1 -52.7 -- --
BSE Healthcare
18.0 0.9 10.3 17.1 22.7 14.0 12.3
As on 02-Sep-2026
Company
2025
2024
2023
EVOQ Remedies
-61.0 -46.8 3.9
BSE Small Cap
-6.6 29.0 47.5
BSE Healthcare
-3.3 43.1 37.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
EVOQ Remedies
1.6 4.0 11.8 0.1 -- 0.3 -- 0.1
6,868.0 17,175.6 2,432.1 169.6 8.7 20.8 101.3 19.0
2,720.5 20,634.9 2,287.3 678.1 31.4 19.7 31 5.5
2,054.2 12,544.9 1,479.1 198.6 18.6 30.3 63 15.5
1,288.9 17,918.8 3,229.7 666.9 26.6 18.8 27.8 4.4
2,408.9 38,730.8 4,147.8 709.5 22.3 19.1 54.6 9.3
4,627.6 21,168.2 2,569.8 735.2 34.4 19.2 28.8 4.8
5,669.5 9,427.0 1,432.9 356.9 30.8 58.2 26.4 15.3
928.6 18,155.9 1,682.5 273.5 21.0 11.1 61.1 6.8
1,047.8 9,653.3 5,004.4 635.3 14.5 19.8 15.7 2.9

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About EVOQ Remedies

Wholesale of pharmaceutical and medical goods

  • Incorporated

    2010

  • Chairman

    --

  • Managing Director

    Bhumishth Patel

  • Headquarters

    Ahmedabad, Gujarat

  • Website

    www.evoqremedies.com

FAQs for EVOQ Remedies

The share price of EVOQ Remedies Ltd is ₹1.62 (BSE) as of 02-Sep-2026 IST. EVOQ Remedies Ltd has given a return of -52.74% in the last 3 years.

Since, TTM earnings of EVOQ Remedies Ltd is negative, P/E ratio is not available.
The P/B ratio of EVOQ Remedies Ltd is 0.09 times as on 02-Sep-2026, a 98 discount to its peers’ median range of 4.65 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
72.32
0.14
2024
26.07
0.47
2023
10.91
0.71
2022
28.17
1.33
2021
0.00
0.00

The 52-week high and low of EVOQ Remedies Ltd are Rs 6.11 and Rs 1.53 as of 02-Sep-2026.

EVOQ Remedies Ltd has a market capitalisation of ₹ 4 Cr as on 02-Sep-2026. As per SEBI classification, it is a Small Cap company.

Before investing in EVOQ Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...